China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 10.01 billion. The enterprise value is 8.17 billion.
| Market Cap | 10.01B |
| Enterprise Value | 8.17B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Share Statistics
SHE:301087 has 226.10 million shares outstanding. The number of shares has increased by 5.71% in one year.
| Current Share Class | 199.10M |
| Shares Outstanding | 226.10M |
| Shares Change (YoY) | +5.71% |
| Shares Change (QoQ) | +4.60% |
| Owned by Insiders (%) | 10.27% |
| Owned by Institutions (%) | 13.25% |
| Float | 101.05M |
Valuation Ratios
The trailing PE ratio is 24.56 and the forward PE ratio is 22.20.
| PE Ratio | 24.56 |
| Forward PE | 22.20 |
| PS Ratio | 2.39 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | 43.74 |
| P/OCF Ratio | 27.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.36, with an EV/FCF ratio of 35.68.
| EV / Earnings | 19.60 |
| EV / Sales | 1.95 |
| EV / EBITDA | 13.36 |
| EV / EBIT | 19.41 |
| EV / FCF | 35.68 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.48 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.96 |
| Debt / FCF | 5.23 |
| Interest Coverage | 22.32 |
Financial Efficiency
Return on equity (ROE) is 8.24% and return on invested capital (ROIC) is 10.22%.
| Return on Equity (ROE) | 8.24% |
| Return on Assets (ROA) | 3.72% |
| Return on Invested Capital (ROIC) | 10.22% |
| Return on Capital Employed (ROCE) | 7.41% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | 822,810 |
| Profits Per Employee | 81,999 |
| Employee Count | 5,081 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, SHE:301087 has paid 69.66 million in taxes.
| Income Tax | 69.66M |
| Effective Tax Rate | 14.30% |
Stock Price Statistics
The stock price has increased by +3.66% in the last 52 weeks. The beta is 0.61, so SHE:301087's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +3.66% |
| 50-Day Moving Average | 52.13 |
| 200-Day Moving Average | 52.23 |
| Relative Strength Index (RSI) | 37.26 |
| Average Volume (20 Days) | 2,288,784 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 4.18 billion and earned 416.64 million in profits. Earnings per share was 1.92.
| Revenue | 4.18B |
| Gross Profit | 2.28B |
| Operating Income | 420.70M |
| Pretax Income | 487.05M |
| Net Income | 416.64M |
| EBITDA | 543.91M |
| EBIT | 420.70M |
| Earnings Per Share (EPS) | 1.92 |
Balance Sheet
The company has 3.08 billion in cash and 1.20 billion in debt, with a net cash position of 1.88 billion or 8.31 per share.
| Cash & Cash Equivalents | 3.08B |
| Total Debt | 1.20B |
| Net Cash | 1.88B |
| Net Cash Per Share | 8.31 |
| Equity (Book Value) | 5.38B |
| Book Value Per Share | 23.65 |
| Working Capital | 2.84B |
Cash Flow
In the last 12 months, operating cash flow was 369.80 million and capital expenditures -140.88 million, giving a free cash flow of 228.92 million.
| Operating Cash Flow | 369.80M |
| Capital Expenditures | -140.88M |
| Depreciation & Amortization | 123.21M |
| Net Borrowing | 157.63M |
| Free Cash Flow | 228.92M |
| FCF Per Share | 1.01 |
Margins
Gross margin is 54.62%, with operating and profit margins of 10.06% and 9.97%.
| Gross Margin | 54.62% |
| Operating Margin | 10.06% |
| Pretax Margin | 11.65% |
| Profit Margin | 9.97% |
| EBITDA Margin | 13.01% |
| EBIT Margin | 10.06% |
| FCF Margin | 5.48% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.83%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 90.48% |
| FCF Payout Ratio | 178.59% |
| Buyback Yield | -5.71% |
| Shareholder Yield | -1.88% |
| Earnings Yield | 4.07% |
| FCF Yield | 2.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for SHE:301087 is 65.12, which is 38.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 65.12 |
| Price Target Difference | 38.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 22.72% |
| EPS Growth Forecast (3Y) | 24.60% |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 4.19 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.19 |
| Piotroski F-Score | 6 |